Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenqi Liujun Cancer Suppression Decoction + modified Zhengqi Powder is a Traditional Chinese Medicine (TCM) combination therapy being evaluated for its effects on immune regulation and the intestinal microbiota in patients with colorectal cancer. The formula is specifically designed for patients characterized by spleen deficiency and dampness toxicity according to TCM theory. It aims to modulate the host immune response and restore microbial balance in the gut, potentially serving as an adjunctive therapy to standard oncological care. The development is led by The Traditional Chinese Medicine Hospital Affiliated to Southwest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhenqi Liujun Cancer Suppression Decoction + modified Zhengqi Powder.